Latest filing published 12 Oct 2026 for Shanghai Henlius Biotech, Inc. - H Shares, €113k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Zhu Jun: trading record in brief
Zhu Jun discloses dealings in Shanghai Henlius Biotech, Inc. - H Shares to HKEX. We count 4 filings; the first trade dates from 27 June 2026 and the latest from 9 October 2026.
The open-market side counts 2 purchases for €113k alongside 1 sale for €670k. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 12 October 2026, reports an open-market purchase of €113k in Shanghai Henlius Biotech, Inc. - H Shares. Filings reach the HKEX feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Zhu Jun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ HK$49.92ShareXHKGHKEX:DA20261012E00030Canonical exit: 7 Jan 2027 (T+90)
- 1,500,000 sharesShareXHKGHKEX:DA20260722E00566Canonical exit: 15 Oct 2026 (T+90)
- 91,445 shares@ HK$65.72840.019% mcap100.0% of flowShareXHKGHKEX:DA20260710E00528
- 375,000 sharesShareXHKGHKEX:DA20260702E00451
4 of 4 declarations